Statistics for PMV Pharmaceuticals, (id:8227 PMVP)
Valuation metrics
Market cap
80.73M
Enterprise value
-86,261,120.00
Trailing P/E (ttm)
-1.12
Forward P/E
-0.99
PEG ratio
-0.99
Price/Sales (ttm)
Price/Book (mrq)
0.41
Enterprise Value/Revenue
Enterprise Value/EBITDA
1.12
Overview
Shares outstanding
51.75M
Float
41.45M
Shares short
847.18K
% Held by insiders
0.02%
% Held by institutions
0.81%
Average volume (10 days)
223.71K
Average volume (90 days)
Price summary
52-Week low
1.40
52-Week high
3.47
52-Week change
-44.72%
Beta
1.48
50-Day moving average
1.57
200-Day moving average
1.67
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-20.27%
Return on equity
-23.63%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-77,121,000.00
Net income to common (ttm)
-51,465,000.00
Diluted EPS (ttm)
-1.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
182.84M
Total cash per share (mrq)
3.53
Total debt (mrq)
13.27M
Total Debt/Equity (mrq)
6.70
Current ratio (mrq)
1.40K%
Book value per share (mrq)
3.82
Cash flow
Cash flow statement
-46,706,000.00
Levered free cash flow (LFCF)
-39,677,624.00